Christopher E. Martin

1.8k citations

27 papers · 1.4k indexed · 1 hit paper · h-index 19

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- T-cell and B-cell Immunology
Microbiology top 5%

Papers in ⓘ

Oncology 10
- CAR-T cell therapy research 10
Immunology 7
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4

Co-authors: Peter H. Seeberger (12 shared papers)Takayuki Ota (1 shared paper)Amanda L. Gavin (1 shared paper)Bruce Beutler (1 shared paper)Bao Duong (1 shared paper)David Nemazee (1 shared paper)Kasper Hoebe (1 shared paper)Chakkumkal Anish (7 shared papers)
Journals: Blood (5 papers)Cancer Research (3 papers)Scientific Reports (2 papers)Chemical Communications (2 papers)Journal of the American Chemical Society (2 papers)
Partner nations: Germany United States South Korea

In The Last Decade

Christopher E. Martin

27 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling 2006 · 469 citations

Peers

Countries citing papers authored by Christopher E. Martin

Since Specialization

Citations

This map shows the geographic impact of Christopher E. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Martin more than expected).

Fields of papers citing papers by Christopher E. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Martin. The network helps show where Christopher E. Martin may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher E. Martin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher E. Martin Line = papers co-authored together Christopher E. Martin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling Science ·Amanda L. Gavin, Kasper Hoebe, Bao Duong, Takayuki Ota, Christopher E. Martin, Bruce Beutler, David Nemazee Hit paper breakdown →	2006	469
2	Interleukin-7 Availability Is Maintained by a Hematopoietic Cytokine Sink Comprising Innate Lymphoid Cells and T Cells Immunity ·Christopher E. Martin, Darina Spasova, Kwesi Frimpong-Boateng, Hee‐Ok Kim, Minji Lee, Kwang Soon Kim, Charles D. Surh	2017	98
3	The aged lymphoid tissue environment fails to support naïve T cell homeostasis Scientific Reports ·Bryan R. Becklund, Jared F. Purton, Chris Ramsey, Stéphanie Favre, Tobias K. Vogt, Christopher E. Martin, Darina Spasova, Gor Sarkisyan, Eric M. Leroy, Joyce T. Tan, Heidi Wahlus, Brea Bondi-Boyd, Sanjiv A. Luther, Charles D. Surh	2016	91
4	Immunological Evaluation of a Synthetic Clostridium difficile Oligosaccharide Conjugate Vaccine Candidate and Identification of a Minimal Epitope Journal of the American Chemical Society ·Christopher E. Martin, Felix Broecker, Matthias A. Oberli, Julia Komor, Jochen Mattner, Chakkumkal Anish, Peter H. Seeberger	2013	79
5	Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) Blood ·Tara Gregory, Adam D. Cohen, Caitlin Costello, Syed Abbas Ali, Jesús G. Berdeja, Eric Ostertag, Christopher E. Martin, Devon J. Shedlock, M. Resler, Matthew A. Spear, Robert Z. Orlowski, Krina K. Patel	2018	70
6	Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans Nature Communications ·Felix Broecker, Jonas Hanske, Christopher E. Martin, Ju Yuel Baek, Annette Wahlbrink, Felix Wojcik, Laura Hartmann, Christoph Rademacher, Chakkumkal Anish, Peter H. Seeberger	2016	58
7	Total synthesis of the core tetrasaccharide of Neisseria meningitidislipopolysaccharide, a potential vaccine candidate for meningococcal diseases Chemical Science ·You Yang, Christopher E. Martin, Peter H. Seeberger	2011	53
8	Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5 Proceedings of the National Academy of Sciences ·Marilda P. Lisboa, Naeem Khan, Christopher E. Martin, Fei‐Fei Xu, Katrin Reppe, Andreas Geissner, Subramanian Govindan, Martin Witzenrath, Claney L. Pereira, Peter H. Seeberger	2017	46
9	Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine Chemical Communications ·Christopher E. Martin, Felix Broecker, Steffen Eller, Matthias A. Oberli, Chakkumkal Anish, Claney L. Pereira, Peter H. Seeberger	2013	44
10	Diversity-oriented Synthesis of Inner Core Oligosaccharides of the Lipopolysaccharide of Pathogenic Gram-negative Bacteria Journal of the American Chemical Society ·You Yang, Shunsuke Oishi, Christopher E. Martin, Peter H. Seeberger	2013	43
11	Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit Chemical Communications ·Christopher E. Martin, Markus Weishaupt, Peter H. Seeberger	2011	37
12	Immunogenicity and Diagnostic Potential of Synthetic Antigenic Cell Surface Glycans of Leishmania ACS Chemical Biology ·Chakkumkal Anish, Christopher E. Martin, Annette Wahlbrink, Christian Bogdan, Pantelis Ntais, Μαρία Αντωνίου, Peter H. Seeberger	2013	35
13	Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites Scientific Reports ·Uwe Möginger, Anja Resemann, Christopher E. Martin, Sharavathi G. Parameswarappa, Subramanian Govindan, Eike‐Christian Wamhoff, Felix Broecker, Detlev Suckau, Claney L. Pereira, Chakkumkal Anish, Peter H. Seeberger, Daniel Kolarich	2016	32
14	Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections Cell chemical biology ·Felix Broecker, Christopher E. Martin, Erik Wegner, Jochen Mattner, Ju Yuel Baek, Claney L. Pereira, Chakkumkal Anish, Peter H. Seeberger	2016	32
15	A Self-Assembling Peptide Scaffold for the Multivalent Presentation of Antigens Biomacromolecules ·Elsa Zacco, Chakkumkal Anish, Christopher E. Martin, Hans von Berlepsch, Enrico Brandenburg, Peter H. Seeberger, Beate Koksch	2015	30
16	A Novel Bcma-Specific, Centyrin-Based CAR-T Product for the Treatment of Multiple Myeloma Blood ·David Hermanson, Burton E. Barnett, Srinivas Rengarajan, Rebecca Codde, Xinxin Wang, Yening Tan, Christopher E. Martin, Jenessa B. Smith, Jin He, Rohit Mathur, Jing Yan, Sattva S. Neelapu, Eric M. Osertag, Devon J. Shedlock	2016	30
17	Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology ·Susan F. Slovin, Tanya B. Dorff, Gerald S. Falchook, Xiao X. Wei, Xīn Gào, Rana R. McKay, David Y. Oh, Andreas G. Wibmer, Matthew A. Spear, Joanne McCaigue, Devon J. Shedlock, Manjima Dhar, Julia Coronella, Christopher E. Martin, Majid Ghodussi, Ann Murphy, Eric Ostertag	2022	29
18	IL-7/anti–IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R Blood ·Christopher E. Martin, Ester M. M. van Leeuwen, Se Jin Im, Derry C. Roopenian, Young‐Chul Sung, Charles D. Surh	2013	28
19	Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections ACS Chemical Biology ·Felix Broecker, Erik Wegner, Bruna M. S. Seco, Paulina Kapłonek, Maria Bräutigam, Armin Ensser, Frederick Pfister, Christoph Daniel, Christopher E. Martin, Jochen Mattner, Peter H. Seeberger	2019	22
20	piggyBacTM-Produced CAR-T Cells Exhibit Stem-Cell Memory Phenotype Blood ·Burton E. Barnett, David Hermanson, Jenessa B. Smith, Xinxin Wang, Yening Tan, Christopher E. Martin, Eric M. Osertag, Devon J. Shedlock	2016	17

About Christopher E. Martin

Christopher E. Martin is a scholar working on Oncology, Immunology, Infectious Diseases, Microbiology and Molecular Biology, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Viral gastroenteritis research and epidemiology (6 papers), Clostridium difficile and Clostridium perfringens research (6 papers), Glycosylation and Glycoproteins Research (5 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). The work is most often cited by research in Immunology (688 citations), Microbiology (105 citations), Infectious Diseases (168 citations), Organic Chemistry (247 citations) and Molecular Biology (517 citations). Christopher E. Martin has collaborated with scholars based in Germany, United States and South Korea. Frequent co-authors include Peter H. Seeberger, Takayuki Ota, Amanda L. Gavin, Bruce Beutler, Bao Duong, David Nemazee, Kasper Hoebe, Chakkumkal Anish, Felix Broecker and You Yang. Their work appears in journals such as Blood, Cancer Research, Scientific Reports, Chemical Communications and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact